Our mission is simple: to save lives through early detection of breast cancer. When breast cancer is detected in stage 1, the five-year relative survival rate is 99%.1
The Enhanced Breast Cancer Detection (EBCD) program is a breakthrough in early detection. It uses artificial intelligence to help radiologists detect even subtle lesions. Combined with exceptionally high-quality mammography systems, EBCD's artificial intelligence (AI) optimizes breast cancer screening, giving women greater confidence in their results.
It's simple. Improved detection means improved outcomes. Women who want to take control of their health choose EBCD to reinforce that first line of defense against breast disease.
What’s included in EBCD:
After your exam, Artificial Intelligence (AI) technology2 is applied to your mammogram.
The AI points out areas of interest on your exam to help the radiologist detect very subtle abnormalities.
After your radiologist reads your exam, the AI performs a second review.
Certain exams with suspicious findings are reviewed by a second radiologist for determination of final results.
Why Choose EBCD?
- One in eight women will develop cancer in her lifetime.3 It is crucial to detect the disease early, when treatment options are most optimal.
- Our AI technology has been shown to improve cancer detection rates and reduce the number of recalls for additional exams.4
- No additional radiation or time during your visit is required. You safely gain the benefit of state-of-the-art screening.
1. American Cancer Society. Survival Rates for Breast Cancer
2. Saige-DX™ Artificial Intelligence, powered by DeepHealth.
3. American Cancer Society. Key Statistics for Breast Cancer
4. Study results available in Saige-Dx™ Instructions for Use.